000			02211nam a22004575i 4500
001			978-3-540-34506-0
003			DE-He213
005			20161121230741.0
007			cr nn 008mamaa
008			100301s2007 gw | s |||| 0|eng d
020			_a9783540345060 _9978-3-540-34506-0
024	7		_a10.1007/978-3-540-34506-0 _2doi
050		4	_aRB45
072		7	_aMJF _2bicssc
072		7	_aMED038000 _2bisacsh
082	0	4	_a616.15 _223
100	1		_aMelo, Junia V. _eauthor.
245	1	0	_aMyeloproliferative Disorders _h[electronic resource] / _cby Junia V. Melo, John M. Goldman.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2007.
300			_aXI, 354 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aHematologic Malignancies
505	0		_aChronic Myeloid Leukemia — A Brief History -- Bcr-Abl and Signal Transduction -- Chronic Myeloid Leukemia: Biology of Advanced Phase -- Clinical Features of CML -- Signal Transduction Inhibitors in Chronic Myeloid Leukemia -- Treatment with Tyrosine Kinase Inhibitors -- Allogeneic Transplantation for CML -- Autografting in Chronic Myeloid Leukemia -- Monitoring Disease Response -- New Therapies for Chronic Myeloid Leukemia -- Immune Therapy of Chronic Myelogenous Leukemia -- Therapeutic Strategies and Concepts of Cure in CML -- BCR-ABL-Negative Chronic Myeloid Leukemia -- Hypereosinophilic Syndrome -- Chronic Idiopathic Myelofibrosis -- Polycythemia Vera — Clinical Aspects -- Polycythemia Vera and Other Polycythemic Disorders — Biological Aspects -- Essential Thrombocythemia.
650		0	_aMedicine.
650		0	_aHematology.
650		0	_aOncology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aHematology.
650	2	4	_aOncology.
700	1		_aGoldman, John M. _eauthor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783540345053
830		0	_aHematologic Malignancies
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-540-34506-0
912			_aZDB-2-SME
950			_aMedicine (Springer-11650)
999			_c503420 _d503420